The D2 dopamine receptor gene (DRD2) is inconsistently implicated in substance abuse, Alzheimer's disease, schizophrenia, and PTSD (Noble 2003). This evidence concerns the gene DRD2 and early-onset autosomal dominant Alzheimer disease.